Skip to main content
EJNMMI Research
Fig. 2 | EJNMMI Research

Fig. 2

From: Early response monitoring of neoadjuvant chemotherapy using [18F]FDG PET can predict the clinical outcome of extremity osteosarcoma

Fig. 2

Kaplan-Meier survival curves of the events-free survival depending on the [18F]FDG PET parameters including SUV2 (a), Δ%SUV01 (b), Δ%SUV02 (c), and histologic response (d). SUV2 is the SUVmax of the primary tumor after completion of neoadjuvant chemotherapy. Δ%SUV01 is the percentage change in SUVmax between baseline and interim of [18F]FDG PET. Δ%SUV02 is the percentage change in SUVmax between baseline and post-therapy of [18F]FDG PET/CT

Back to article page